Prof. Jae-Hyung Park and Dong-kyu Cho selected as regular members of KAST
The Korean Academy of Science and Technology announced on the 20th that it had elected 28 full members for the year 2023 at the '2022 2nd...
top of page
앵커 1
Communication
- Sep 27, 2022
The 'stem cell' challenge continues in the 'osteoarthritis' treatment market
[Medigate News Reporter Seo Min-ji] Although the number of patients with degenerative arthritis increases worldwide every year due to the...
- Apr 21, 2022
Exostemtech applied for phase 1 clinical trial IND in Korea for an exosome-based osteoarthritis trea
"EST-P-EXO1" aims to regenerate damaged cartilage tissue and suppress pain Bio-venture Exostemtech has applied for the domestic clinical...
- Jan 6, 2022
Daewoong Pharmaceutical and ExostemTech, joint development agreement for exosome treatment
Daewoong's 'DW-MSC' exosome extraction, purification and joint development of new indications Daewoong Pharmaceutical will join hands...
- Nov 19, 2021
[Jump-Up Bio] Exostemtech said, "The first clinical trial in Korea next year...He's even going to ge
[Anchor comment] Today's JumpUp Bio introduces Exostemtech, which develops stem cell exosome treatments. It aims to enter clinical trials...
bottom of page